DNA X, Inc. (SONM): R&D Expense
$14.23M
Year ended 2024-12-31
-7.0%
3-year compound annual growth
-11.4%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $14.23M | +703.3% | 2025-03-31, From 2024-01-01 |
| 2023-12-31 | $1.77M | -77.8% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $7.97M | -54.9% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $17.70M | +9.1% | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | $16.22M | -37.8% | 2022-06-29, From 2020-01-01 |
| 2019-12-31 | $26.06M | +12.1% | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | $23.25M | n/a | 2020-03-27, From 2018-01-01 |